Renaissance Technologies - KARUNA THERAPEUTICS INC ownership

KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 259 filers reported holding KARUNA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.43 and the average weighting 1.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of KARUNA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$2,320
-88.8%
10,700
-90.6%
0.00%
-88.9%
Q1 2023$20,689
-65.4%
113,900
-62.5%
0.03%
-67.1%
Q4 2022$59,736
-99.9%
304,000
-13.1%
0.08%
-26.1%
Q3 2022$78,726,000
+2204.6%
350,000
+1196.3%
0.11%
+2675.0%
Q2 2022$3,416,000
+667.6%
27,000
+694.1%
0.00%
+300.0%
Q4 2021$445,000
-77.9%
3,400
-87.9%
0.00%
-50.0%
Q1 2020$2,016,00028,0000.00%
Other shareholders
KARUNA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 797,008$134,766,08353.75%
Nan Fung Group Holdings Ltd 225,688$38,161,58430.90%
Sofinnova Investments, Inc. 1,381,149$233,538,48414.73%
First Light Asset Management, LLC 303,137$51,257,4354.87%
Altium Capital Management LP 34,000$5,749,0603.00%
DAFNA Capital Management LLC 52,873$8,940,2962.78%
Logos Global Management LP 115,000$19,445,3502.59%
GENERAL ATLANTIC, L.P. 986,710$166,842,7942.58%
MPM BioImpact LLC 53,210$8,997,2792.40%
Rock Springs Capital Management LP 505,433$85,463,6662.29%
View complete list of KARUNA THERAPEUTICS INC shareholders